119 related articles for article (PubMed ID: 15404935)
1. [Medullary plasma and pseudo-plasma cells in neoplasms].
MOREL P
Sang; 1949; 20(9):602-8. PubMed ID: 15404935
[No Abstract] [Full Text] [Related]
2. [Myelosclerosis : pseudo-tumors forms (author's transl)].
Waitz R; Mayer G; Mayer S; Oberling F; Lang JM
Nouv Rev Fr Hematol (1978); 1978; 20(4):501-19. PubMed ID: 377222
[TBL] [Abstract][Full Text] [Related]
3. Calcitonin in plasma and cerebrospinal fluid from normal subjects and patients with medullary thyroid carcinoma: possible restriction of calcitonin by the blood-brain barrier.
Morimoto S; Nishimura J; Miyauchi A; Takai S; Okada Y; Onishi T; Fukuo K; Lee S; Kumahara Y
J Clin Endocrinol Metab; 1982 Sep; 55(3):594-6. PubMed ID: 7096542
[TBL] [Abstract][Full Text] [Related]
4. Migration into pseudo-follicles of draining lymph nodes of medullary small thymocytes injected in the mediastinal cavity.
Sainte-Marie C; Peng FS
Rev Can Biol; 1975 Dec; 34(4):205-12. PubMed ID: 1084540
[TBL] [Abstract][Full Text] [Related]
5. High permanent plasma adrenaline levels: a marker of adrenal medullary disease in medullary thyroid carcinoma.
Vistelle R; Grulet H; Gibold C; Chaufour-Higel B; Delemer B; Fay R; Delisle MJ; Caron J
Clin Endocrinol (Oxf); 1991 Feb; 34(2):133-8. PubMed ID: 1673649
[TBL] [Abstract][Full Text] [Related]
6. [Radioimmunoassay of the calcitonin gene-related peptide and its measurement in the plasma of patients with medullary thyroid carcinoma and in the cerebrospinal fluid of normal subjects].
Kim S; Morimoto S; Fukuo K; Hironaka T; Koh E; Shiraishi T; Onishi T; Kumahara Y; Kawai Y; Shiotani Y
Nihon Naibunpi Gakkai Zasshi; 1987 Jul; 63(7):884-93. PubMed ID: 3500074
[TBL] [Abstract][Full Text] [Related]
7. [Decalcifying aleukemic plasmocytosis; Pseudo-osteoalacic medullary form with hyperglobulinemia; Decalcifying aleukemic mycosis with plasma cells with hyperglobulinemia].
COMBEY P; CREYSSEL R; GUICHARD A; MEGARD M
Lyon Med; 1956 Nov; 88(47):453-7. PubMed ID: 13386418
[No Abstract] [Full Text] [Related]
8. Cellular transport of l-arginine determines renal medullary blood flow in control rats, but not in diabetic rats despite enhanced cellular uptake capacity.
Persson P; Fasching A; Teerlink T; Hansell P; Palm F
Am J Physiol Renal Physiol; 2017 Feb; 312(2):F278-F283. PubMed ID: 27927650
[TBL] [Abstract][Full Text] [Related]
9. Class distribution of immunoglobulin-containing plasma cells in the stroma of medullary carcinoma of breast.
Ito T; Saga S; Nagayoshi S; Imai M; Aoyama A; Yokoi T; Hoshino M
Breast Cancer Res Treat; 1986; 7(2):97-103. PubMed ID: 3013350
[TBL] [Abstract][Full Text] [Related]
10. Radioiodide uptake and turnover in a pseudo-medullary thyroid carcinoma.
Spencer RP; Garg V; Raisz LG; Karimeddini MK; Penikas V; Yamase H; Forouhar F
J Nucl Med; 1982 Nov; 23(11):1006-10. PubMed ID: 7131083
[TBL] [Abstract][Full Text] [Related]
11. [Hematological changes in medullary metastases of malignant tumors].
ZOGRAFOV D
Suvr Med (Sofiia); 1960; 11(11)():33-40. PubMed ID: 13788734
[No Abstract] [Full Text] [Related]
12. Sensitivity of the renal medullary circulation to plasma vasopressin.
Franchini KG; Cowley AW
Am J Physiol; 1996 Sep; 271(3 Pt 2):R647-53. PubMed ID: 8853387
[TBL] [Abstract][Full Text] [Related]
13. Renal medullary blood flow and renal medullary antihypertensive mechanisms.
Bergström G; Göthberg G; Karlström G; Rudenstam J
Clin Exp Hypertens; 1998 Jan; 20(1):1-26. PubMed ID: 9507785
[TBL] [Abstract][Full Text] [Related]
14. Coexistence of medullary thyroid carcinoma and recurrent non-functional pituitary adenoma: a case report.
Bagherzadeh M; Aminorroaya A; Vafaeimanesh J; Mohajeri-Tehrani MR
J Med Case Rep; 2018 Aug; 12(1):220. PubMed ID: 30107852
[TBL] [Abstract][Full Text] [Related]
15. Blood group antigen expression in malignant tumors of the thyroid: a parallel between medullary and nonmedullary carcinomas.
Larena A; Vierbuchen M; Fischer R
Langenbecks Arch Chir; 1995; 380(5):269-72. PubMed ID: 7500798
[TBL] [Abstract][Full Text] [Related]
16. Plasma somatostatin in normal subjects and in various diseases: increased levels in somatostatin-producing tumors.
Saito H; Saito S
Horm Metab Res; 1982 Feb; 14(2):71-6. PubMed ID: 6121747
[TBL] [Abstract][Full Text] [Related]
17. [Morphology and histochemistry of medullary thyroid carcinomas (author's transl)].
Katenkamp D; Stiller D
Zentralbl Allg Pathol; 1974; 118(6):519-32. PubMed ID: 4466214
[TBL] [Abstract][Full Text] [Related]
18. Role of medullary plasma flow in the attenuated furosemide response in indomethacin-treated rats.
Kirchner KA
J Pharmacol Exp Ther; 1989 Jun; 249(3):757-61. PubMed ID: 2732945
[TBL] [Abstract][Full Text] [Related]
19. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
Komminoth P
Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
[TBL] [Abstract][Full Text] [Related]
20. [Radioimmunoassay of plasma calcitonin gene-related peptide (CGRP) levels in patients with endocrine tumor].
Takami H; Shikata J; Horie H; Horiuchi J; Sakurai H; Ito K
Gan To Kagaku Ryoho; 1989 Jun; 16(6):2219-25. PubMed ID: 2786708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
